CN Patent

CN106074427A — 一种马来酸阿法替尼片剂及其制备方法

Assigned to Nanjing Cuccess Pharmaceutical Co., Ltd. · Expires 2016-11-09 · 10y expired

What this patent protects

一种马来酸阿法替尼片剂及其制备方法。马来酸阿法替尼片由片芯和包裹在片芯外的薄膜包衣组成，该片剂以一水乳糖、微晶纤维素PH301为填充剂，交联聚维酮为崩解剂，二氧化硅为助流剂，硬脂酸镁为润滑剂。本发明采用干法制粒技术制备该片剂，可以改善流动性，防止各成分离析，以避免片剂成分不均匀，调整堆密度，改善溶解性能，改善片剂生产中压力的均匀传递等优点。

USPTO Abstract

一种马来酸阿法替尼片剂及其制备方法。马来酸阿法替尼片由片芯和包裹在片芯外的薄膜包衣组成，该片剂以一水乳糖、微晶纤维素PH301为填充剂，交联聚维酮为崩解剂，二氧化硅为助流剂，硬脂酸镁为润滑剂。本发明采用干法制粒技术制备该片剂，可以改善流动性，防止各成分离析，以避免片剂成分不均匀，调整堆密度，改善溶解性能，改善片剂生产中压力的均匀传递等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN106074427A
Jurisdiction
CN
Classification
—
Expires
2016-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Cuccess Pharmaceutical Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.